We are live on ! Find out more
TC

TFS Capital Portfolio holdings

AUM $255M
1-Year Est. Return 32.31%
This Fund
S&P 500
This Quarter Est. Return
+6.26%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
10 Year Est. Return
AUM
$1.02B
AUM Growth
-$27.3M
Cap. Flow
-$59.1M
Cap. Flow %
-5.79%
Top 10 Hldgs %
6.58%
Holding
1,337
New
372
Increased
249
Reduced
312
Closed
397

Sector Composition

Rank Sector Weight
1 Healthcare 17.42%
2 Industrials 13.36%
3 Technology 13.09%
4 Consumer Discretionary 11.84%
5 Financials 6.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GNCMA
26
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
$4.87M 0.48%
308,961
-15,425
-5% -$226K
ITGR icon
27
Integer Holdings
ITGR
$3.35B
$4.85M 0.48%
91,989
-37,628
-29% -$1.79M
NOR
28
DELISTED
NORANDA ALUM HLDG CORP COM NEW
NOR
$4.78M 0.47%
230,086
+177,485
+337% +$3.97M
MWW
29
DELISTED
Monster Worldwide Inc
MWW
$4.71M 0.46%
742,701
+462,253
+165% +$2.53M
AMPH icon
30
Amphastar Pharmaceuticals
AMPH
$825M
$4.62M 0.45%
308,624
+294,637
+2,107% +$3.94M
COHU icon
31
Cohu
COHU
$2.39B
$4.56M 0.45%
417,116
+297,286
+248% +$3.37M
RDEN
32
DELISTED
ELIZABETH ARDEN INC
RDEN
$4.49M 0.44%
+288,101
New +$4.8M
SIGM
33
DELISTED
Sigma Designs Inc
SIGM
$4.49M 0.44%
559,498
+125,722
+29% +$898K
LCI
34
DELISTED
Lannett Company, Inc.
LCI
$4.46M 0.44%
16,463
-11,651
-41% -$2.65M
ARRY
35
DELISTED
Array Biopharma Inc
ARRY
$4.44M 0.43%
+602,451
New +$4.29M
TVRD
36
Tvardi Therapeutics
TVRD
$23.5M
$4.42M 0.43%
12,214
+9,752
+396% +$3.69M
IIP
37
DELISTED
INTERNAP NETWORK SERVICES CORPORATION
IIP
$4.37M 0.43%
+427,522
New +$4.37M
CYNO
38
DELISTED
Cynosure, Inc. Class A
CYNO
$4.31M 0.42%
140,647
-10,939
-7% -$330K
EBS icon
39
Emergent Biosolutions
EBS
$375M
$4.29M 0.42%
149,318
+15,963
+12% +$458K
CKP
40
DELISTED
CHECKPOINT SYSTEMS INC
CKP
$4.27M 0.42%
395,000
+148,808
+60% +$1.89M
NAT icon
41
Nordic American Tanker
NAT
$1.37B
$4.22M 0.41%
+357,331
New +$3.78M
STGW icon
42
Stagwell
STGW
$1.84B
$4.16M 0.41%
+146,856
New +$3.71M
PGNX
43
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$4.13M 0.4%
689,759
+226,019
+49% +$1.42M
XCRA
44
DELISTED
Xcerra Corporation
XCRA
$4.12M 0.4%
463,567
+278,768
+151% +$2.4M
EBSB
45
DELISTED
Meridian Bancorp, Inc.
EBSB
$4.11M 0.4%
311,751
+16,546
+6% +$201K
PDLI
46
DELISTED
PDL BioPharma, Inc.
PDLI
$4.04M 0.4%
574,801
+389,576
+210% +$2.82M
EXAC
47
DELISTED
Exactech Inc
EXAC
$4M 0.39%
156,024
+60,690
+64% +$1.4M
SXI icon
48
Standex International
SXI
$3.68B
$3.88M 0.38%
+47,203
New +$3.5M
BBBY
49
Bed Bath & Beyond
BBBY
$473M
$3.81M 0.37%
209,644
-57,249
-21% -$994K
TMHC icon
50
Taylor Morrison
TMHC
$6.67B
$3.81M 0.37%
182,787
+23,751
+15% +$444K

Similar funds

TFS Capital's Q1 2015 Portfolio in Review

As of Q1 2015, TFS Capital held 1,337 positions worth $1.02B, down 2.6% from $1.05B the previous quarter. Its ten largest holdings account for 6.6% of the portfolio.

TFS Capital withdrew a net $59.1M in Q1 2015, closing 397 positions and reducing 312 holdings. Its most notable exit was Infinity Pharmaceuticals, Inc., an estimated $5.86M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Technology.

Against the trend, TFS Capital opened a new position in Terex worth $6.13M.

  • TFS Capital's largest Q1 2015 buy was Terex: 230,720 shares worth $6.13M.
  • TFS Capital added most to Civeo in Q1 2015, an estimated $6.63M increase.
  • TFS Capital's biggest Q1 2015 reduction was Dauch Corp, cutting an estimated $5.23M.
  • TFS Capital fully exited Infinity Pharmaceuticals, Inc. in Q1 2015, selling an estimated $5.86M.
  • TFS Capital's ten largest holdings make up 6.6% of its $1.02B portfolio in Q1 2015.
  • TFS Capital opened 372 new positions and closed 397 in Q1 2015.
  • TFS Capital's portfolio value fell 2.6% quarter-over-quarter to $1.02B.

Based on TFS Capital's 13F filing for Q1 2015, filed 29 Apr 2015.